These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27581436)

  • 1. Synergistic Neutralization of Pertussis Toxin by a Bispecific Antibody In Vitro and In Vivo.
    Wagner EK; Wang X; Bui A; Maynard JA
    Clin Vaccine Immunol; 2016 Nov; 23(11):851-862. PubMed ID: 27581436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking.
    Acquaye-Seedah E; Huang Y; Sutherland JN; DiVenere AM; Maynard JA
    Cell Microbiol; 2018 Dec; 20(12):e12948. PubMed ID: 30152075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cocktail of humanized anti-pertussis toxin antibodies limits disease in murine and baboon models of whooping cough.
    Nguyen AW; Wagner EK; Laber JR; Goodfield LL; Smallridge WE; Harvill ET; Papin JF; Wolf RF; Padlan EA; Bristol A; Kaleko M; Maynard JA
    Sci Transl Med; 2015 Dec; 7(316):316ra195. PubMed ID: 26631634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.
    Sutherland JN; Chang C; Yoder SM; Rock MT; Maynard JA
    Clin Vaccine Immunol; 2011 Jun; 18(6):954-62. PubMed ID: 21508166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons.
    Nguyen AW; DiVenere AM; Papin JF; Connelly S; Kaleko M; Maynard JA
    Sci Adv; 2020 Feb; 6(6):eaay9258. PubMed ID: 32076653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody that neutralizes pertussis toxin activities.
    Pootong A; Budhirakkul P; Tongtawe P; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):37-45. PubMed ID: 17891920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay.
    Dalby T; Sørensen C; Petersen JW; Krogfelt KA
    APMIS; 2010 Dec; 118(12):968-72. PubMed ID: 21091778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7.
    Sutherland JN; Maynard JA
    Biochemistry; 2009 Dec; 48(50):11982-93. PubMed ID: 19899804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.
    Halperin SA; Issekutz TB; Kasina A
    J Infect Dis; 1991 Feb; 163(2):355-61. PubMed ID: 1703192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody.
    Huang S; Li F; Liu H; Ye P; Fan X; Yuan X; Wu Z; Chen J; Jin C; Shen B; Feng J; Zhang B
    MAbs; 2018; 10(6):864-875. PubMed ID: 30081724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis.
    Eby JC; Gray MC; Warfel JM; Merkel TJ; Hewlett EL
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27760780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of neutralising human recombinant antibodies to pertussis toxin.
    Williamson P; Matthews R
    FEMS Immunol Med Microbiol; 1999 Apr; 23(4):313-9. PubMed ID: 10225291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Specificity Following a Recent
    Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
    Front Immunol; 2019; 10():1364. PubMed ID: 31275314
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.
    Sato H; Ito A; Chiba J; Sato Y
    Infect Immun; 1984 Nov; 46(2):422-8. PubMed ID: 6094351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization.
    Acquaye-Seedah E; Reczek EE; Russell HH; DiVenere AM; Sandman SO; Collins JH; Stein CA; Whitehead TA; Maynard JA
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of monoclonal antibody to pertussis toxin on toxin activity.
    Sato H; Sato Y; Ito A; Ohishi I
    Infect Immun; 1987 Apr; 55(4):909-15. PubMed ID: 2435660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural relationship between the S1 and S4 subunits of pertussis toxin.
    Sato H; Sato Y
    FEMS Microbiol Lett; 1994 Jan; 115(1):63-9. PubMed ID: 7510256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Anti-PT Antibody Response after Pertussis Vaccination and Infection: The Importance of Both Quantity and Quality.
    Barkoff AM; Knuutila A; Mertsola J; He Q
    Toxins (Basel); 2021 Jul; 13(8):. PubMed ID: 34437379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.
    Carbonetti NH; Artamonova GV; Andreasen C; Dudley E; Mays RM; Worthington ZE
    Infect Immun; 2004 Jun; 72(6):3350-8. PubMed ID: 15155640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.